ilShinbiobase Co. Ltd (068330) — Capital Reinvestment Ratio
Latest as of March 2026:
0.01x
ilShinbiobase Co. Ltd (068330) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩3.46 Billion) in capital expenditures (₩38.55 Million). See 068330 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.46 Billion
KRW
Capital Expenditures
₩38.55 Million
KRW
Data as of
Mar 2026
Most recent filing
ilShinbiobase Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks ilShinbiobase Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for ilShinbiobase Co. Ltd from 2014 to 2025. For live market cap and broader valuation context, see ilShinbiobase Co. Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | ₩5.27 Billion | ₩20.64 Million | ▼ -69.8% |
| 2024 | 0.01x | ₩4.12 Billion | ₩53.53 Million | ▼ -70.6% |
| 2023 | 0.04x | ₩5.92 Billion | ₩262.17 Million | ▼ -77.6% |
| 2022 | 0.20x | ₩2.65 Billion | ₩522.59 Million | ▲ +857.4% |
| 2021 | 0.02x | ₩6.74 Billion | ₩139.12 Million | ▼ -89.6% |
| 2020 | 0.20x | ₩4.50 Billion | ₩892.64 Million | ▲ +348.1% |
| 2019 | 0.04x | ₩5.55 Billion | ₩245.41 Million | ▼ -44.1% |
| 2018 | 0.08x | ₩4.88 Billion | ₩385.81 Million | ▼ -59.0% |
| 2017 | 0.19x | ₩2.11 Billion | ₩407.59 Million | ▲ +113.2% |
| 2016 | 0.09x | ₩3.01 Billion | ₩271.94 Million | ▼ -75.4% |
| 2015 | 0.37x | ₩270.22 Million | ₩99.39 Million | ▲ +1105.2% |
| 2014 | 0.03x | ₩3.33 Billion | ₩101.50 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow